Pathways involved in regulating treatment resistance and apoptosis as regulated by L1CAM include PI3K/Akt signaling in gastric cancer [49], retinoblastoma [56] and neuroblastoma [53]. This evidence concerns the gene AKT1 and neuroblastoma.